From unexpected diagnosis to DIAGNODE-3 participant
Katie Howell was diagnosed with type 1 diabetes last year at age 25. Now, she's the first DIAGNODE-3 trial participant…
Noticias Y Actualizaciones
Discover stories from Breakthrough T1D about our research, advocacy, initiatives, and supporters.
Lo más reciente
Lee las últimas noticias de Breakthrough T1D.
ATTD 2025: Closing the loop to cures
At ATTD 2025, Breakthrough T1D led sessions showcasing advancements in T1D cell therapies, early detection, and technology to improve lives.
Gearing up for the Breakthrough T1D Ride 2025 season
We’re gearing up for an incredible Breakthrough T1D Ride 2025 season. Check out this year's beautiful destinations and ride with…
From Breakthrough T1D trainee to Principal Investigator: Kelsey Voss, Ph.D., is calling the shots
Kelsey Voss, Ph.D., received Breakthrough T1D's Advanced Postdoctoral Fellowship Award, which helped start her lab at UVA studying T cells…
Breakthrough T1D 2025 Government Day: 4 amazing days, 485 Congressional meetings, 370 sore feet
Breakthrough T1D headed to Washington D.C. where advocates held nearly 500 meetings with Members of Congress on behalf of the…
Challenges and solutions: The present and future of cell therapies for T1D
Breakthrough T1D is funding research that supports manufactured islet cell source, survival, and protection and is also driving initiatives to…
Artículos recientes
Comunicados de prensa
Lee los últimos comunicados de prensa y declaraciones de Breakthrough T1D.
¡Vaya! No hemos podido localizar tu formulario.
